Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCQX - Delayed Quote USD

BioLargo, Inc. (BLGO)

Compare
0.2600
-0.0057
(-2.15%)
At close: March 14 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,492
--
5,884
2,531
2,432
Cost of Revenue
10,301
--
3,027
1,428
1,204
Gross Profit
8,191
--
2,857
1,103
1,228
Operating Expense
11,498
--
7,913
7,464
8,563
Operating Income
-3,307
--
-5,056
-6,361
-7,335
Net Non Operating Interest Income Expense
-31
--
-53
-234
-1,923
Other Income Expense
-132
--
-23
-299
-442
Pretax Income
-3,635
--
-5,132
-6,894
-9,700
Net Income Common Stockholders
-2,117
--
-4,473
-7,080
-8,432
Diluted NI Available to Com Stockholders
-2,117
--
-4,473
-7,080
-8,432
Basic EPS
-0.01
-0.02
-0.02
-0.03
-0.05
Diluted EPS
-0.01
-0.02
-0.02
-0.03
-0.05
Basic Average Shares
295,355.0340
285,956.8520
268,302.2340
247,203.6250
195,993.5750
Diluted Average Shares
295,355.0340
285,956.8520
268,302.2340
247,203.6250
195,993.5750
Total Operating Income as Reported
-3,721
--
-5,390
-6,778
-7,583
Total Expenses
21,799
--
10,940
8,892
9,767
Net Income from Continuing & Discontinued Operation
-2,117
--
-4,473
-7,080
-8,432
Normalized Income
-1,820
--
-4,450
-6,781
-7,990
Interest Expense
31
--
53
234
1,923
Net Interest Income
-31
--
-53
-234
-1,923
EBIT
-3,604
--
-5,079
-6,660
-7,777
EBITDA
-3,328
--
-5,034
-6,640
-7,719
Reconciled Cost of Revenue
10,301
--
3,027
1,428
1,204
Reconciled Depreciation
276
--
45
20
58
Net Income from Continuing Operation Net Minority Interest
-2,117
--
-4,473
-7,080
-8,432
Total Unusual Items Excluding Goodwill
-297
--
-23
-299
-442
Total Unusual Items
-297
--
-23
-299
-442
Normalized EBITDA
-3,031
--
-5,011
-6,341
-7,277
12/31/2020 - 3/22/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers